UpFront
-
Ten interesting things we read this week
Some of the most fascinating topics covered this week are: Lifestyle (There's a name for the blah you're feeling), Leadership (4 important lessons from the pandemic for the future of work), Healthcare (Inside India's big pharma-drug distributor team-up) and Climate Change (We're hurtling toward global suicide).
-
Tackling India's oxygen emergency: Can there be a timely, cost-effective solution?
Hospitals and individuals are raising an SOS, civil society is on its toes, courts are stepping in, and industries are diverting resources for medical use. As caseloads increase, Forbes India explores the way forward to ensure timely and cost-effective access to oxygen for Covid-19 treatment
-
How the Super League fell apart
While soccer is the biggest business in sports, it remains, at heart, an intensely local affair with teams rooted in neighbourhoods and based in small towns, competing in leagues that have existed for more than a century
-
Jack Ma shows why China's tycoons keep quiet
Under the Communist Party's top leader, Xi Jinping, China has punished and shamed a series of tycoons who amassed enormous wealth and influence but were seen to overstep their bounds
-
How to double mask correctly
Double masking, now validated by the CDC and Dr Anthony Fauci, can help filter more particles than a single mask or cloth mask. Here are the crucial dos and donts
-
Earth Day 2021: Nature and its nemesis—how humans are trampling biodiversity globally
Humans are wreaking havoc on the Earth's biodiversity and many species of animals are being driven to extinction, as people impinge on the world's natural resources
-
Why the $5 billion Hero group wants a pie of India's booming edtech space
Akshay Munjal has taken it upon himself to solve the problem of underemployment and unemployment with Hero Vired. The online learning platform offers an end-to-end learning ecosystem for professional development and makes students industry-ready for employment
-
Covid-19: Post-vaccination coronavirus cases miniscule
Data released Wednesday shows that per 10,000 people, the rate of infections among persons who have taken either the first or second dose of Bharat Biotech's Covaxin or Serum Institute's Covishield is extremely low
-
Apple's new devices target markets led by smaller rivals
The company has unveiled a series of new products that showed how it continues to centre its marketing pitch on consumer privacy while muscling into new markets pioneered by much smaller competitors
-
India's health system cracks under the strain as coronavirus cases surge
India is now home to the world's fastest-growing Covid-19 crisis, reporting 314,000 new infections on Thursday and more than 2,000 deaths
-
Explained: How do ventilators save lives?
A look at the different components that make up the ventilator, and why it's important in Covid-19 treatment